麻豆AV

KalGene gears up to manufacture and test promising Alzheimer鈥檚 treatment with NRC, 麻豆AV and CIMTEC

KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed...

• Read more about KalGene gears up to manufacture and test promising Alzheimer鈥檚 treatment with NRC, 麻豆AV and CIMTEC